« Back to Record
Citation APA

Roufosse, F., Butterfield, J. H., Steinfeld, J., Bentley, J. J., von Maltzahn, R., Kwon, N., & Nelsen, L. (2023). Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome. Frontiers in Medicine, 10, 1035250. doi:10.3389/fmed.2023.1035250


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/366954

Roufosse, F., Butterfield, J. H., Steinfeld, J., Bentley, J. J., von Maltzahn, R., Kwon, N., & Nelsen, L. (2023). Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome. Frontiers in Medicine, 10, 1035250. doi:10.3389/fmed.2023.1035250